Pharmaceuticals
India bans Pfizer, Abbot cough syrups; shares tank
14 Mar 2016
The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
Govt panel recommends cap on profits to control drug prices
09 Mar 2016
The committee set up by the Department of Pharmaceuticals has recommended capping of trade margins of costly drugs at 35 per cent of maximum retail price
End-game for dengue as Indian scientists develop herbal remedy
09 Mar 2016
Indian scientists have developed an effective herbal medicine for the treatment of dengue, in what could be a potent remedy to the disease that affects millions of people within the country and across the world
Whistleblower Dinesh Thakur takes pharma regulators to court
07 Mar 2016
Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures
Drug firms ripping off patients with fixed doses?
04 Mar 2016
The US federal Medicare programme and private health insurers waste nearly $3 billion every year buying cancer medicines that are thrown out because many drug makers distribute the drugs only in vials that hold too much for most patients, a group of cancer researchers has found
Allergen deal to help Pfizer save $35 bn in annual taxes: report
26 Feb 2016
The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States
US FDA approves Glenmark's oral contraceptives
24 Feb 2016
Biocon gets EU nod for generic cholesterol drug
16 Feb 2016
Intercept Pharmaceuticals explores sale
15 Feb 2016
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
